Eighteen hybridoma cell lines were used to study species-specific, stage-specific, and serological cross-reactive antigens of the rodent malarial parasite, Plasmodium yoelii. Specificity and location of plasmodial antigens were determined by indirect fluorescent-antibody analysis. Results showed that a minimum of 12 distinct plasmodial antigens could be distinguished by the 18 hybridomas. Antigens were found on the surface or within the cytoplasm of the parasite, but not on the surface of erythrocytes from infected animals. The majority (11 of 12) of antigens were present in all erythrocytic stages of the parasite, but one was stagespecific for merozoites. Additional studies showed that 6 of 18 of the monoclonal antibodies identified species-specific antigens, 2 of 18 recognized antigens confined to related rodent malarial parasites (Plasmodium berghei, Plasmodium vinckei, and Plasmodium chabaudi), whereas 8 of 18 detected cross-reactive antigens common to rodent, primate (Plasmodium knowlesi, Plasmodium falciparum), and avian (Plasmodium gallinaceum) malarias.
During malaria infection antiplasmodial antibodies (Ab's) are produced, but the number, location, and characteristics of many parasite antigens (Ag's) which induce these responses have not been identified (3, 7, 18, 20, 21, 24) . In the past it has been difficult to identify and isolate individual plasmodial antigens and evaluate their roles in production or suppression of immunity. The use of hybridoma technology now makes it possible to produce large amounts of Ab against single antigenic determinants of malarial parasites. Monoclonal Ab's can be used to identify and ultimately to purify malarial Ag's.
It is well established that mice infected with nonlethal (strain 17XNL) Plasmodium yoelii develop protective immunity during primary infection, but mice infected with the lethal (17XL) substrain routinely die (27) . Unfortunately, the immune mechanism(s), including the Ag(s) involved in initiating protective immunity during primary nonlethal malaria, is unknown. Since Ab plays a role in immune protection (11) and since antiplasmodial Ab's appear in the serum of infected mice before peak parasitemias, investigations of plasmodial Ag's which induce humoral responses during the early stages of infection are of interest. Because Ab's produced before peak parasitemia bind to circulating parasites and are removed from the serum, conventional serological and immunochemical techniques are not applicable. Therefore, the most feasible approach was to produce hybridomas by using spleen cells from mice infected 4 to 6 days previously with lethal or nonlethal malaria. Eighteen antiplasmodial hybridoma cell lines were produced by using lymphocytes from infected animals. Then monoclonal Ab's were used to partially characterize P. yoelii Ag's.
MATERIALS AND METHODS
Parasites. The 17XL and 17XNL substrains of P. yoelii were used in this study (26) .
Production of monoclonal Ab's. BALB/c mice (Cumberland View Farms, Clinton, Tenn.) were primed to malarial Ag's either by infection with 106 P. yoelii 17XL parasites 4 days before fusion (group 1) or by infection with 104 P. yoelii 17XNL parasites 4 or 6 days before fusion (groups 2 and 3). The mean parasitemia in the peripheral blood of the three groups of animals at the time of fusion was 17.5, <0.1, and 6.1%, respectively. Spleen cells from malaria-infected mice were fused at a 10:1 ratio with the P3-X63-NS/1 (NS1) cell line by the procedure of Margulies et al. (19) . Culture supernatants collected from microtiter wells 14 days after fusion were screened for antiplasmodial activity by radioimmunoassay (15) or the indirectfluorescent Ab (IFA) technique described below (16) or both. Antiplasmodial hybrids were cloned twice, using a thymocyte feeder layer (2), and ascites fluid was produced in pristane (2,3,6,10-tetramethyl pentadecane; Aldrich Chemical Co., Milwaukee, Wis.)-primed mice.
Hybridoma nomenclature. The hybrid cell lines used in this study have been identified by: (i) an Arabic numeral to designate the number of days after infection the fusion was performed; (ii) the strain of P. yoelii used, i.e., 17X lethal (L) or 17X nonlethal (NL); and (iii) a number to designate the individual hybrid cell line. Thus, hybrid 6NL-3 is the third hybridoma produced by fusion of NS1 and spleen cells from BALB/c mice experimentally infected 6 days previously with the 17XNL strain of P. yoelii.
Purification of antimalarial hybridoma Ab's. Partially purified monoclonal Ab's were prepared by precipitation from pooled ascites fluid with ammonium sulfate at half saturation. After dialysis against phosphate-buffered saline (PBS), the immunoglobulin concentration was determined spectrophotometrically (optical density, 280 nm), using the extinction coefficient for mouse immunoglobulin, E?l% = 1.2. Ab's were diluted to 1 mg/ml in PBS and used at that concentration unless otherwise specified. Serum pooled from BALB/c mice which had recovered from 17XNL infections and subsequent 17XL challenge was treated as described above, adjusted to 1 mg/ml, and used as a source of positive control Ab. To confirm that Ab's present in partially purified ascites fluids were responsible for the results obtained, selected monoclonal Ab's of the immunoglobulin G (IgG) subclass were isolated by protein A Sepharose CL-4B (Pharmacia, Uppsala, Sweden) column chromatography (10).
Isotype analysis. The isotypes of immunoglobulins secreted by in vitro maintained cell lines were determined by polyethylene glycol Ouchterlony analysis (8), using culture supernatants and affinity-purified class-specific reagents (goat antimouse IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA) (22) . In addition, partially purified ascites fluids and purified monoclonal Ab's were analyzed with the above heavy chain-specific reagents by immunoelectrophoresis to insure the presence of a single paraprotein.
IFA staining. The IFA procedure described by Kuvin et al. was used (16) . In brief, smears of peripheral blood from malaria-infected animals were dehemoglobinized, treated with 20 Ml of partially purified ascites fluids (1 mg/ml) for 20 min at room temperature, washed for 15 min in three changes of PBS, and then counterstained for 20 min with fluorescein isothiocyanate-conjugated goat anti-mouse immunoglobulin (GaMIg-a polyvalent reagent containing 3 mg of Ab per ml, with a fluorescein-to-protein ratio of 7). Smears were washed for an additional 15 In each IFA assay, a blood smear was stained with Giemsa stain to verify that all erythrocytic stages were present. Smears of all parasites were prepared and examined at least twice. In synchronous malarial infections, blood was drawn several times during the cycle. However, blood smears containing B. microti did not contain many late-stage parasites.
Partially purified ascites fluids were tested for antiToxoplasma gondii (RH strain) activity by Milton Lunde (Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases), using the techniques of passive hemagglutination (13) or the Sabin-Feldman dye test (23) or both.
Preparation of free parasites for differentiating internal and membrane-associated Ag's. The IFA procedure described above, using smears containing erythrocytic-stage parasites, does not distinguish Ag's located on the outer membranes of parasites from internal plasmodial cytoplasmic Ag's. To determine whether monoclonal Ab's could bind to Ag's on the surface of freed P. yoelii parasites, parasites were released from erythrocytes by the following method before staining. Blood cells from P. yoelii 17XL-infected BALB/c mice were washed three times with PBS, passed through a CF 11 Whatman cellulose column to remove leukocytes (12) , centrifuged, and swollen in the presence of 0.65% sodium chloride. (Fig. 1A) . This pattern of fluorescence resulted when smears were stained with a variety of Ab concentrations (0.01 to 10 mg/ml).
The second pattem of fluorescence (pattern II) was produced by hybridomas, 4L-1, 4L-4, and 4L-6. These Ab's appeared to bind to all erythrocytic stages, but produced enhanced fluorescence around the edge of large parasites (Fig.  1C) .
A group of three hybrids (4L-3, 6NL-6, and 6NL-9) secreted Ab's which bound to all of the erythrocytic stages of P. yoelii when smears were treated with Ab at 1 mg/ml. However, dilution of the Ab to 10 ,tg/ml resulted in characteristic staining pattern III, in which fluorescence was confined to a portion of individual merozoites within schizonts (Fig. 1D-F) . Thus, it appears that all of the erythrocytic stages of the parasite contain low cytoplasmic levels of this Ag(s) but that the Ag(s) is in a higher concentration in a specific region of the merozoite. Of the 18 hybrids, 1 produced Ab to a stagespecific Ag (pattern IV). Ab from hybrid 6NL-10 bound to merozoites within schizonts or to merozoites released from schizonts, but not to the other erythrocytic stages of P. yoelii (Fig.  1G) . At 1 mg of Ab per ml, fluorescence was observed throughout the cell, but upon dilution, fluorescence was noted only in a discrete area of merozoites (Fig. 1H) .
A single pattern of fluorescence was not restricted to a single isotype (Table 1) clearly produce distinguishable patterns of immunofluorescence with both the sporozoite and the erythrocytic stages.
Next, the hybrids were used to determine whether the Ag's recognized by mice during primary malaria were species specific or crossreactive. The results (Table 2) showed that 7 of 18 hybrids detected species-specific Ag's, i.e., Ag's possessed only by P. yoelii. Most of these hybrids (six of seven) produced identical IFA staining, both in terms of intensity and pattern, on the lethal and nonlethal substrains. However, hybridoma 4NL-3 routinely produced moderately stronger fluorescence on nonlethal, compared with lethal, P. yoelii parasites. It is of interest that in this study, all species-specific hybrids were produced by using spleen cells from animals with 4-day lethal or nonlethal malaria. By the techniques employed in this study, it was not possible to differentiate these seven hybrids further. Based on the different patterns of fluorescence achieved by IFA staining, a minimum of two to three Ag's can be distinguished.
The remaining 11 hybrids showed varying degrees of cross-reactivity with rodent, primate, and avian malaria species (Table 2) . Some hybrids (4L-7, 6NL-8, and 4L-5) showed limited cross-reactivity, binding only to one or two VOL. 32, 1981 on October 19, 2017 by guest http://iai.asm.org/ closely related rodent parasites. Three hybrids (4L-8, 4L-3, and 6NL-7) detected Ag's shared by rodent and primate malarias. However, five hybrids demonstrated extensive reactivity by binding to Ag(s) common to rodent and primate malarias plus the avian parasite P. gallinaceum ( Fig. 2B and C) . Four of these hybrids also produced Ab's that bound to Ag(s) of B. microti. Each of the 11 cross-reactive hybrids produced the same pattern of immunofluorescence on various species of Plasmodium as that initially described for P. yoelii. For example, hybrid 6NL-10 was found to bind only to merozoites but not to the other erythrocytic stages of P. yoelii (pattern IV). Ab from hybrid 6NL-10 also detected an Ag restricted to merozoites of the other rodent, primate, and avian malarias tested (Fig. 20) . Based on the results (Tables 1 and 2) plus data on sporozoite cross-reactivity, at least 10 unique Ag's can be differentiated by the 11 non-species-specific hybrids.
Neither immune serum nor the 18 monoclonal Ab's showed serological cross-reactivity with T. gondii ( Table 2) .
Location of P. yoelii Ag's. An attempt was made to determine whether the Ag's recognized by the monoclonal Ab's were (i) present on the surface of erythrocytes from infected animals, (ii) on the surface of the parasite itself or its associated parasitophorous vacuolar membrane, (iii) contained within the cytoplasm of the parasite or whether a combination of these possibilities might be true. Thus, the 18 monoclonal Ab's were surveyed by flow microfluorometry for their ability to bind to the surface of erythrocytes from P. yoelii-infected animals. Although immune serum was observed to bind to the surface of a population of erythrocytes from infected animals (data not shown), none of the monoclonal Ab's examined possessed this characteristic. Similar results were obtained by conventional fluorescence microscopy.
IFA staining of fixed smears containing malarial parasites detects Ag's located on the surface and within the cytoplasm of parasites. To determine which, if any, of the 18 monoclonal Ab's were directed against Ag's on the outer membrane surface of intact parasites, parasites were freed from erythrocytes and stained in suspension. With this technique, a typical pattern of membrane fluorescence was produced by using immune serum ( Fig. 2A) . However, only 1 of the 18 hybrid Ab's (4L-7) was determined to recognize Ag on the surface of intact parasites ( clonal Ab's were screened for their ability to bind to the erythrocytic and sporozoite stages of P. yoelii and to the erythrocytic stages ofrelated rodent, primate, and avian malarias. Monoclonal Ab's also were tested for their ability to detect Ag's on the surface of erythrocytes from infected mice and on malarial parasites mechanically released from erythrocytes. Based on results from this study, the 18 hybrids appeared to detect at least 12 different antigenic determinants. Several of these Ag's were species specific, whereas others showed varying degrees of serological cross-reactivity with other malarial parasites. Ag's were detected on the surface and within the cytoplasm of P. yoelii parasites, but not on the surface of erythrocytes from infected animals. Two Ag's (6NL-9 + 6NL-10) were found to be present in both the erythrocytic and sporozoite stages of P. yoelii. Thus, BALB/c mice respond to a wide variety of parasite Ag's during the early stages of P. yoelii infection.
Previous studies have demonstrated that at least part of the protective immune response of the host is directed against stage-specific Ag's. This point has been well established recently in two studies with monoclonal Ab's. Yoshida et al. used monoclonal Ab's to demonstrate that a single Ag (Pb44) on the surface of P. berghei sporozoites is important in sporozoite immunity (28) . Monoclonal Ab to this stage-specific Ag neutralizes sporozoites in vitro and blocks sporozoite infectivity in vivo. In another study, Freeman et al. showed that monoclonal Ab to a merozoite-specific Ag of P. yoelii is capable of passively protecting mice from lethal P. yoelii malaria (11) . Although mice passively treated with monoclonal Ab developed parasitemias, the course of infection was similar to that observed in mice with nonlethal malaria.
One stage-specific Ag (6NL-10) was identified in our study. This merozoite-specific (Ag) was not species specific as monoclonal Ab 6NL-10 bound to merozoites of all of the rodent, primate, and avian malarial parasites tested. Our preliminary results suggest that Ab from 6NL-10 is not protective and that the Ag may be associated with an internal merozoite organelle. As trophozoites develop into merozoites, nuclear structures, rhoptries, micronemes, and a surface coat are formed (1, 17, 20) . Since Ab from 6NL-10 (i) did not bind to the surface of merozoites, (ii) was restricted primarily to a definite area of merozoites, and (iii) bound to two areas of sporozoites (which also possess rhoptries and similar accessory organelles), Ag 6NL-10 is probably associated with structures involved in nuclear division or organelles important in cell penetration. However, the observation that BALB/c mice infected with P. yoelii 17XNL for 6 days produce an Ab which binds to a "universal" merozoite Ag is an interesting finding that deserves further investigation.
One predicted use for monoclonal Ab's is for taxonomic studies of malarial parasites. During the evolutionary adaptation ofmalarial parasites to various hosts, some Ag's have been retained, i.e., conserved, whereas others have been acquired and develop as species-species Ag's. Various investigators have demonstrated serological cross-reactivity among the rodent malarial parasites P. berghei, P. chabaudi, and P. vinckei (5, 6, 9) , among primate malarias (4), and between human and primate (25) and human and avian malarias (14) . However, it has not been possible (i) to establish how many Ag's are involved in serological cross-reactivity, (ii) to determine whether common Ag's have taxonomic significance, or (iii) to determine whether crossreactive determinants are located on homologous molecules, i.e., molecules with equivalent biological functions. Some of these questions may be approached by hybridoma technology. Our results suggest that serological cross-reactivity may be due to numerous antigenic determinants. For example, all of the rodent, primate, and avian malarial parasites we tested were capable of binding Ab from three hybridomas which have different antigenic specificities ([4NL-2 + 6NL-5], [6NL-6 + 6NL-9], and 6NL-10). One cannot conclude, however, that the observed serological cross-reactivity denotes the presence of homologous molecules in the above parasites. Ag's which bind monoclonal Ab's must be isolated from each species of malarial parasites and biochemically analyzed before taxonomic interrelationships can be established.
In this investigation, serological cross-reactivity studies were used to help differentiate the antigenic specificity of antimalarial hybrid cell lines. Currently, monoclonal Ab's from these hybridomas are being used to isolate and further characterize Ag's which induce humoral immune responses in malaria-infected mice.
